The patterns and dynamics of genomic instability in metastatic pancreatic cancer
Peter J. Campbell;Peter J. Campbell;Shinichi Yachida;Laura J. Mudie;Philip J. Stephens.
Multiple-laboratory comparison of microarray platforms
Rafael A Irizarry;Daniel Warren;Forrest Spencer;Irene F Kim.
Nature Methods (2005)
Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR
David J. Vandenbergh;Antonio M. Persico;Anita L. Hawkins;Constance A. Griffin.
Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds
Alison P. Klein;Kieran A. Brune;Gloria M. Petersen;Michael Goggins.
Cancer Research (2004)
Recurrent Involvement of 2p23 in Inflammatory Myofibroblastic Tumors
Constance A. Griffin;Anita L. Hawkins;Cecily Dvorak;Carol Henkle.
Cancer Research (1999)
ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor.
Cheryl M. Coffin;Ankita Patel;Sherrie Perkins;Kojo S J Elenitoba-Johnson.
Modern Pathology (2001)
Frequent Detection of Pancreatic Lesions in Asymptomatic High-Risk Individuals
Marcia Irene Canto;Ralph H. Hruban;Elliot K. Fishman;Ihab R. Kamel.
Screening for Early Pancreatic Neoplasia in High-Risk Individuals: A Prospective Controlled Study
Marcia Irene Canto;Michael Goggins;Ralph H. Hruban;Gloria M. Petersen.
Clinical Gastroenterology and Hepatology (2006)
Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.
Kathleen M. Murphy;Kieran A. Brune;Constance Griffin;Jennifer E. Sollenberger.
Cancer Research (2002)
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach
Marcia Irene Canto;Michael Goggins;Charles J. Yeo;Constance Griffin.
Clinical Gastroenterology and Hepatology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: